FDA approves Inlyta to treat patients with a type of advanced kidney cancer

January 27, 2012, 12:09 pm by FDA US Food & Drug Administration

The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

Read the full article

More from FDA US Food & Drug Administration

Federal government gains permanent injunction against raw milk producer
FDA US Food & Drug Administration : February 22, 2012, 4:24 am
A federal court has granted the U.S. Food and Drug Administration a permanent injunction preventing Daniel L. Allgyer and his Rainbow Acres Farm from distributing raw milk and raw milk products in

FDA acts to bolster supply of critically needed cancer drugs
FDA US Food & Drug Administration : February 21, 2012, 10:18 am
The U.S. Food and Drug Administration today announced a series of steps to increase the supply of critically needed cancer drugs and build on President Obama’s Executive Order to help prevent future

FDA approves Korlym for patients with endogenous Cushing’s syndrome
FDA US Food & Drug Administration : February 17, 2012, 4:08 am
Today, Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome. This drug was approved for use in

FDA approves Zioptan to treat elevated eye pressure
FDA US Food & Drug Administration : February 14, 2012, 5:54 am
On February 10, the U.S. Food and Drug Administration approved Zioptan (tafluprost ophthalmic solution) to help reduce elevated eye pressure in people with open-angle glaucoma.

New Jersey company agrees to halt production of unapproved dental devices
FDA US Food & Drug Administration : February 13, 2012, 11:26 am
Accurate Set Inc., of Newark, N.J., and the company’s president and owner, Cornell L. Adams, have agreed to stop manufacturing and distributing medical devices as part of a consent decree of permanent